Psychedelics Space at a ‘Tipping Point’ as Compass, Definium Gear Up To File for Approval

With Lykos’ regulatory failure now squarely in the rearview mirror, Compass Pathways and Definium are leading what one analyst suspects will be “a very big year for psychedelics.”